Editas Medicine所有资讯

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(10.71%),SSGA FUNDS MANAGEMENT, INC.(8.50%)

04/10 21:42

Editas Medicine | 4：持股变动声明-高管 Lucera Erick

03/06 09:09

Editas Medicine | 4：持股变动声明-高管 Burkly Linda

03/06 09:09

Editas Medicine | 4：持股变动声明-高管 O'Neill Gilmore Neil

03/06 09:05

Editas Medicine | 4：持股变动声明-高管 Mei Baisong

03/06 08:59

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-Deep Track Capital, LP(6.70%),Deep Track Biotechnology Master Fund, Ltd.(6.70%)等

02/14 21:42

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(10.36%)

02/14 07:06

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(9.6%)

01/25 03:35

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(6.21%)

01/10 13:00

Editas Medicine | 4：持股变动声明-高管 Eaton Bruce

2023/12/08 05:30

Editas Medicine | 4：持股变动声明-高管 Eaton Bruce

2023/11/17 05:30

Editas Medicine | 4：持股变动声明-高管 Eaton Bruce

2023/11/10 05:31

Editas Medicine | 4：持股变动声明-高管 Eaton Bruce

2023/09/08 04:59

Editas Medicine | 4：持股变动声明-高管 Eaton Bruce

2023/08/16 04:30

Editas Medicine | 4：持股变动声明-高管 Eaton Bruce

2023/08/11 04:30

Editas Medicine | SC 13G：超过5%持股股东披露文件-Deep Track Capital, LP(5.51%),Deep Track Biotechnology Master Fund, Ltd.(5.51%)等

2023/08/05 04:17

Editas Medicine | 4：持股变动声明-高管 Burkly Linda

2023/07/26 04:45

Editas Medicine | 3：首次持股声明-高管 Burkly Linda

2023/07/26 04:29

Editas Medicine | 4：持股变动声明-高管 Mei Baisong

2023/07/22 04:30

Editas Medicine | 4：持股变动声明-首席执行官 O'Neill Gilmore Neil

2023/06/08 04:30